Resources

Corsano launched commercialization of its CardioWatch EU-MDR certified patient monitoring bracelet on cobas® pulse, a digitally enabled professional blood glucose management solution from Roche.

We are thrilled to announce that our CEO Peter Stas presented Corsano Health's innovative CardioWatch solution at HIMSS24 Startup Competition in Rome. This prestigious event showcases groundbreaking health tech and we are honored to be recognized among the best.

Corsano Health is announcing that its CardioWatch 287-2 System received FDA Clearance.

Collaborating researchers from Radboud University Medical Center, Erasmus MC, Reinier de Graaf Hospital, and Corsano Health have succeeded in reliably measuring whether a patient's circulation stops, as in the case of cardiac arrest.

Cisco and Corsano closely collaborated on the new Cisco Platform for In-Hospital Monitoring of patients. The revolutionary solution was showcased at Cisco Live 2024. The Corsano Bracelet streamed Vital Signs over BLE to Cisco’s latest router live at the Cisco Live event. We are proud to be Cisco’s Wearable Partner.

Radboud University Medical Center (RadboudUMC) has initiated a donation campaign to support the DETECT Cardiac Arrest project. This vital initiative aims to enhance the detection and response strategies for cardiac arrests, potentially saving numerous lives.

Dr. Eelko Ronner PhD presented study findings from a collaboration with Reinier de Graaf Hospital that found Cuffless NIBP resulted in accurate prediction of blood pressure based on an AI Pulse Wave Analysis model.

August 28, 2023, the Research Team of Reinier de Graaf Hospital presented results of the Corsano Cuffless Non-Invasive Blood Pressure at the ESC in Amsterdam.

Corsano Health is launching the company’s CardioWatch EU-MDR certified patient monitoring bracelet with Cuffless Non-Invasive Blood Pressure at ESC in Amsterdam…

Sepsis is a life-threatening emergency. Under the leadership of Dr. Matthias Gründling, SepsisDialog has been working on the early detection and treatment of sepsis for about 30 years.

Corsano’s CardioWatch EU-MDR certified patient monitoring bracelet will connect to cobas® pulse, Roche’s digitally enabled professional blood glucose management solution, combining multiple health applications in one device.

Corsano Health is launching the company’s second-generation EU-MDR wearable device that accurately measures eight vital parameters and makes raw PPG and ACC data available for further analysis by third party medical algorithm developers.

Revolutionizing the use of patient centric data in correlating effective clinical outcomes.

This technology should save thousands of lives: recognise cardiac arrests and sound an alarm. Corsano Health CardioWatch in Radboudumc Cardiac Arrest Clinical Trial.

As the benefits of remote patient monitoring (RPM) grow increasingly evident, wearable devices emerge as the revolutionary reformation of health assessment.

Corsano Health CardioWatch in Radboudumc Cardiac Arrest Clinical Trial Every year, approximately 17,000 Dutch people suffer a cardiac arrest outside the hospital. 7000 to 8000 this happens without someone being there to alert the emergency services. Radboudumc in Nijmegen and Corsano Health are now working on a special smartwatch.

Notified Body DARE!! Services B.V. declares that it has audited the quality assurance system in accordance with MDR Annex IX and that the relevant provisions of the Regulation 2017/745 dated May 5, 2017 concerning Medical Devices are fulfilled.

We are happy to announce that Corsano Health B.V. is medically certified complying with Annex IX (MDR) and EN-ISO 13485 standards.

We are proud to announce that the Dutch Heart Foundation awarded Corsano Health a development project to recognize cardiac arrest and alert emergency services. Survival of Out-of-Hospital Cardiac Arrest (OHCA) depends on early recognition of Cardiac Arrest and initiation of Cardiopulmonary Resuscitation (CPR).